TOVX

THERIVA BIOLOGICS INC

TOVX·87164U508·US·Common Stock·Healthcare - Biotechnology-13D/G

TOVX (THERIVA BIOLOGICS INC) is held by 14 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($88,161), VANGUARD FIDUCIARY TRUST CO ($47,389), UBS Group AG ($44,223). Net institutional sentiment: Mixed.

14
Holders
Avg rating(3 Elite)
$280,111
Total Value
57% (16)
Fund Consensus
8 buying - 6 selling
TOVXSmart Money Verdict
View all
Held by 14 funds
3 elite
Who's Trading
ActivistJMJeffrey Matthew Gryga Irrevocable Trust7.7%Nov 10, 2025
ActivistEAEmpery Asset Management, LP5.0%Oct 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
450,263(+112.3%)$88,1610.0%+0.93%
24
New
241,780$47,3890.0%+26.32%
31
Increased
225,624(+17.9%)$44,2230.0%+9.69%
16
New
192,404$37,7110.0%+26.32%
31
New
177,034$34,6640.0%+26.32%
30
Increased
94,620(+139.9%)$18,5270.0%-10.85%
30
Decreased
23,602(-88.2%)$4,6210.0%+20.00%
0
Decreased
15,441(-63.5%)$3,0230.0%-40.00%
0
Unchanged
7,504$1,4690.0%-84.00%
0
Decreased
1,391(-77.5%)$2720.0%+20.00%
0
New
253,218$500.0%+26.32%
15
Decreased
8(-98.2%)$10.0%-96.01%
0
Unchanged
1$00.0%-83.89%
0
Exited
0(-100.0%)$6,8530.0%-5.00%
0
New
1$00.0%+26.32%
17
Exited
0(-100.0%)$6,5390.0%-5.83%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used